Literature DB >> 35032456

Myofibril orientation as a metric for characterizing heart disease.

Weikang Ma1, Henry Gong2, Vivek Jani3, Kyoung Hwan Lee4, Maicon Landim-Vieira5, Maria Papadaki6, Jose R Pinto5, M Imran Aslam7, Anthony Cammarato8, Thomas Irving2.   

Abstract

Myocyte disarray is a hallmark of many cardiac disorders. However, the relationship between alterations in the orientation of individual myofibrils and myofilaments to disease progression has been largely underexplored. This oversight has predominantly been because of a paucity of methods for objective and quantitative analysis. Here, we introduce a novel, less-biased approach to quantify myofibrillar and myofilament orientation in cardiac muscle under near-physiological conditions and demonstrate its superiority as compared with conventional histological assessments. Using small-angle x-ray diffraction, we first investigated changes in myofibrillar orientation at increasing sarcomere lengths in permeabilized, relaxed, wild-type mouse myocardium from the left ventricle by assessing the angular spread of the 1,0 equatorial reflection (angle σ). At a sarcomere length of 1.9 μm, the angle σ was 0.23 ± 0.01 rad, decreased to 0.19 ± 0.01 rad at a sarcomere length of 2.1 μm, and further decreased to 0.15 ± 0.01 rad at a sarcomere length of 2.3 μm (p < 0.0001). Angle σ was significantly larger in R403Q, a MYH7 hypertrophic cardiomyopathy model, porcine myocardium (0.24 ± 0.01 rad) compared with wild-type myocardium (0.14 ± 0.005 rad; p < 0.0001), as well as in human heart failure tissue (0.19 ± 0.006 rad) when compared with nonfailing samples (0.17 ± 0.007 rad; p = 0.01). These data indicate that diseased myocardium suffers from greater myofibrillar disorientation compared with healthy controls. Finally, we showed that conventional, histology-based analysis of disarray can be subject to user bias and/or sampling error and lead to false positives. Our method for directly assessing myofibrillar orientation avoids the artifacts introduced by conventional histological approaches that assess myocyte orientation and only indirectly evaluate myofibrillar orientation, and provides a precise and objective metric for phenotypically characterizing myocardium. The ability to obtain excellent x-ray diffraction patterns from frozen human myocardium provides a new tool for investigating structural anomalies associated with cardiac diseases.
Copyright © 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35032456      PMCID: PMC8874025          DOI: 10.1016/j.bpj.2022.01.009

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  50 in total

1.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.

Authors:  Robert L Anderson; Darshan V Trivedi; Saswata S Sarkar; Marcus Henze; Weikang Ma; Henry Gong; Christopher S Rogers; Joshua M Gorham; Fiona L Wong; Makenna M Morck; Jonathan G Seidman; Kathleen M Ruppel; Thomas C Irving; Roger Cooke; Eric M Green; James A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 11.205

Review 3.  Synchrotron radiation imaging for advancing our understanding of cardiovascular function.

Authors:  Mikiyasu Shirai; Daryl O Schwenke; Hirotsugu Tsuchimochi; Keiji Umetani; Naoto Yagi; James T Pearson
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

4.  Passive tension in cardiac muscle: contribution of collagen, titin, microtubules, and intermediate filaments.

Authors:  H L Granzier; T C Irving
Journal:  Biophys J       Date:  1995-03       Impact factor: 4.033

5.  Titin strain contributes to the Frank-Starling law of the heart by structural rearrangements of both thin- and thick-filament proteins.

Authors:  Younss Ait-Mou; Karen Hsu; Gerrie P Farman; Mohit Kumar; Marion L Greaser; Thomas C Irving; Pieter P de Tombe
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 6.  Desmin: a major intermediate filament protein essential for the structural integrity and function of muscle.

Authors:  Denise Paulin; Zhenlin Li
Journal:  Exp Cell Res       Date:  2004-11-15       Impact factor: 3.905

7.  Pacemaker-induced transient asynchrony suppresses heart failure progression.

Authors:  Jonathan A Kirk; Khalid Chakir; Kyoung Hwan Lee; Edward Karst; Ronald J Holewinski; Gianluigi Pironti; Richard S Tunin; Iraklis Pozios; Theodore P Abraham; Pieter de Tombe; Howard A Rockman; Jennifer E Van Eyk; Roger Craig; Taraneh G Farazi; David A Kass
Journal:  Sci Transl Med       Date:  2015-12-23       Impact factor: 17.956

8.  Reduced Right Ventricular Sarcomere Contractility in Heart Failure With Preserved Ejection Fraction and Severe Obesity.

Authors:  M Imran Aslam; Virginia S Hahn; Vivek Jani; Steven Hsu; Kavita Sharma; David A Kass
Journal:  Circulation       Date:  2020-12-02       Impact factor: 29.690

9.  Heart Failure in Humans Reduces Contractile Force in Myocardium From Both Ventricles.

Authors:  Cheavar A Blair; Elizabeth A Brundage; Katherine L Thompson; Arnold Stromberg; Maya Guglin; Brandon J Biesiadecki; Kenneth S Campbell
Journal:  JACC Basic Transl Sci       Date:  2020-07-22

Review 10.  Heart Plasticity in Response to Pressure- and Volume-Overload: A Review of Findings in Compensated and Decompensated Phenotypes.

Authors:  Fotios G Pitoulis; Cesare M Terracciano
Journal:  Front Physiol       Date:  2020-02-13       Impact factor: 4.566

View more
  1 in total

Review 1.  Small Angle X-ray Diffraction as a Tool for Structural Characterization of Muscle Disease.

Authors:  Weikang Ma; Thomas C Irving
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.